These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25852947)

  • 1. The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD.
    Buchan A; Bennett R; Coad A; Barnes S; Russell R; Manuel AR
    Open Heart; 2015; 2(1):e000052. PubMed ID: 25852947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction.
    Adrish M; Nannaka VB; Cano EJ; Bajantri B; Diaz-Fuentes G
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1183-1189. PubMed ID: 28458528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.
    Su X; Lei T; Yu H; Zhang L; Feng Z; Shuai T; Guo H; Liu J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():811-825. PubMed ID: 37197601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
    Andrijevic I; Milutinov S; Lozanov Crvenkovic Z; Matijasevic J; Andrijevic A; Kovacevic T; Bokan D; Zaric B
    Lung; 2018 Oct; 196(5):583-590. PubMed ID: 29951921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
    Abroug F; Ouanes-Besbes L; Nciri N; Sellami N; Addad F; Hamda KB; Amor AB; Najjar MF; Knani J
    Am J Respir Crit Care Med; 2006 Nov; 174(9):990-6. PubMed ID: 16840745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
    Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of B-Type Natriuretic Peptide in Predicting In-Hospital Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Preserved Left Ventricular Function: A 5-Year Retrospective Analysis.
    Vallabhajosyula S; Haddad TM; Sundaragiri PR; Ahmed AA; Nawaz MS; Rayes HAA; Devineni HC; Kanmanthareddy A; McCann DA; Wichman CS; Modrykamien AM; Morrow LE
    J Intensive Care Med; 2018 Nov; 33(11):635-644. PubMed ID: 27913775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
    Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
    Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
    Ryding AD; Kumar S; Worthington AM; Burgess D
    Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
    Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
    Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations.
    Chen YR; Chen V; Hollander Z; Leipsic JA; Hague CJ; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    PLoS One; 2017; 12(3):e0174063. PubMed ID: 28328968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in biomarkers of cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.
    Shafuddin E; Chang CL; Cooray M; Tuffery CM; Hopping SJ; Sullivan GD; Jacobson GA; Hancox RJ
    Respir Med; 2018 Dec; 145():192-199. PubMed ID: 30509708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased CD34+ cell number is correlated with cardiac dysfunction in patients with acute exacerbation of COPD.
    Liu Y; Liu X; Lin G; Sun L; Li H; Xie C
    Heart Lung Circ; 2014 Sep; 23(9):875-82. PubMed ID: 24875532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
    Chang CL; Robinson SC; Mills GD; Sullivan GD; Karalus NC; McLachlan JD; Hancox RJ
    Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nasal intermittent positive pressure ventilation on N-terminal pro-brain natriuretic peptide in patients with acute exacerbations of chronic obstructive pulmonary disease and type II respiratory failure].
    Wang Y; Yang Y; Chen P; Luo Y; Yang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):325-31. PubMed ID: 22561561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.